GCAC & Genetica Expand Relationship to Include US Cannabis Market
 | |||||||||
 |  |  |  | ||||||
Uplift Discounts Available Nationwide for US Veterans
Vancouver, British Columbia, Canada – TheNewswire - July 18, 2023 – Global Compliance Applications Corp. (“GCAC” or the “Company”) (CSE:APP) (FSE:2FA) (OTC:FUAPF), a leading chain-of-custody compliance and data platform, Genetica, a leading provider of AI technology for the cannabis industry, is excited to announce the expansion of its strategic partnership[1] into the U.S. market. This expansion brings the transformative power of the Citizen Green Project to a wider audience, delivering personalized recommendations and exclusive discounts to U.S. veterans visiting medical cannabis retailers nationwide.
Through this enhanced collaboration, Genetica's advanced AI technology will provide the most effective product recommendations for U.S. veterans seeking medical cannabis solutions. By leveraging data-driven insights, Genetica aims to ensure that veterans receive tailored suggestions that meet their unique needs and preferences, improving their overall cannabis experience.
Furthermore, as part of the extended partnership, veterans can take advantage of substantial NFT discounts through the innovative Uplift App. This blockchain-powered couponing system, as a keystone component of the Green Project, ensures the utmost respect for consumer privacy while incentivizing purchases and driving foot traffic to participating retailers.
Brad Moore, CEO of GCAC, expressed his excitement about this major milestone for the Company: "Our partnership with Genetica signifies a significant expansion of the Citizen Green Project into the U.S. market. With Genetica's AI capabilities and data insights, we are creating a responsive ecosystem that empowers U.S. veterans in their cannabis-purchasing journey. Through curated deals and personalized recommendations, we aim to elevate their buying experience."
Initial deployment trials of the Citizen Green Project and Uplift in Ohio [2] paved the way for this expansive rollout, making Uplift available in hundreds of retailers where Genetica's AI solution is currently deployed. This development underscores GCAC's commitment to reaching a wider veteran customer base and transforming the medical cannabis retail landscape.
As Genetica's CEO, Ben York, emphasized: "Our deepened collaboration with GCAC and the expansion of the Citizen Green Project into the U.S. represent a significant stride in our mission. By harnessing GCAC's technology and data expertise, we are revolutionizing the industry with valuable insights that enhance customer loyalty and drive revenue growth. Together, we are providing U.S. veterans with the ultimate cannabis retail experience."
Citizen Green Project was designed to bring value to the US veteran community that has no federal support as do Canadian veterans. By connecting a product NFT coupon via an Efixii QR code to a Genetica-selected product means that not only do veterans get access to affordable cannabis they get the right cannabis to use. For retailers and CBD/Cannabis brands interested in participating in the Citizen Green Project they are encouraged to visit: https://citizengreen.io/citizengreen_retailers_c/
About Global Compliance Applications Corp. “GCAC”
GCAC is a global leader in designing and developing innovative blockchain technologies and machine learning solutions to improve real-world businesses. GCAC's leading solution is Efixii, an Ethereum Layer 2 blockchain and EVM programming functionality that is on par with other Layer-2's, such as Polygon. GCAC can quickly connect each participant from product producers, distributors, manufacturers and retailers through a series of value chain dApps that allows for data connectivity to drive better consumer experiences and sales. GCAC created clearESG to assist businesses in communicating their sustainability goals and earned attributes on the blockchain through a series of ESG (Environmental, Social & Governance) merit badges. As an interconnected supply chain solution, the Efixii solution pays tokens for attesting to a product's value, or truthness, through a reward program. GCAC works in many agricultural industries providing a value-added blockchain offering through a cost-effective SaaS licensing model.
For more Company information, please visit www.globalcompliance.app, or review its profiles on www.sedar.com and on the Canadian Securities Exchange's website www.thecse.com.
About Genetica
Established in 2020, Genetica is at the forefront of modernizing the cannabis and CBD industries with Flora AI, its pioneering platform. Flora AI analyzes over 650 million data points to provide precise product recommendations, ensuring customers find the perfect product in line with their needs, biochemistry, and current in-store inventory. This state-of-the-art tool not only enriches the customer experience but also empowers store employees, paving the way for effective upselling and increased loyalty. With a profound understanding of the historical and cultural significance of cannabis, Genetica is committed to helping retailers navigate and thrive in this rapidly evolving market. Experience the transformative power of Flora AI and unlock your cannabis and CBD retail business's full potential. For more information, please visit getgenetica.com.
GCAC Press Contact
Phone: +1 (800) 409-5679
Email: info@GCAC.tech
www.globalcompliance.app
Forward-Looking Information
This news release may include forward-looking information within the meaning of Canadian securities legislation concerning the business of GCAC. Forward-looking information is based on certain key expectations and assumptions made by the management of GCAC. Although management of the Company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because GCAC can give no assurance that they will prove to be correct. Forward-looking statements contained in this news release are made as of the date of this news release. GCAC disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.
The Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy and accuracy of this information.
###